tiprankstipranks
Navigating the AI Minefield: Tango Therapeutics’ Struggle with Security Risks and EU Regulations
Company Announcements

Navigating the AI Minefield: Tango Therapeutics’ Struggle with Security Risks and EU Regulations

Tango Therapeutics, Inc. (TNGX) has disclosed a new risk, in the Cyber Security category.

Don't Miss Our Christmas Offers:

Tango Therapeutics, Inc. faces significant risks with the integration of artificial intelligence (AI) into its operations, particularly with security threats to confidential and proprietary information. The company’s use of generative AI tools, as well as those used by its vendors, could lead to breaches and a loss of intellectual property, potentially damaging its reputation and the public’s trust in its security measures. Moreover, the impending EU Artificial Intelligence Act may impose rigorous ethical and regulatory standards, increasing the burden and cost of compliance. Tango Therapeutics, Inc. must navigate these challenges carefully to protect its business interests and maintain its competitive edge in a rapidly evolving technological landscape.

The average TNGX stock price target is $17.00, implying 102.62% upside potential.

To learn more about Tango Therapeutics, Inc.’s risk factors, click here.

Related Articles
TheFlyTango Therapeutics treatment of pancreatic cancer granted orphan designation
TheFlyTango Therapeutics price target lowered to $8 from $16 at B. Riley
TheFlyTango Therapeutics price target lowered to $8 from $18 at Guggenheim
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App